Review Article
Phytochemistry and Pharmacology of Thymus broussonetii Boiss
Table 5
Anticancer effects of T. broussonetii.
| Parts used | Extracts | Used methods | Cell lines | Key results | References |
| Leaves and stems | Essential oils | Crystal violet assay | The parental human ovarian adenocarcinoma cell line IGR-OV1 (OV1/P) | IC50 = 0.40 ± 0.02%(v/v) | [15] | Flowers and leaves | Essential oils (variety: TbA) | MTT assay | P815 mastocytoma cell line | IC50 = 4.7%(v/v) | [12] | CEM | IC50 = 3.6%(v/v) | K-562 | IC50 = 10%(v/v) | MCF -7 | IC50 = 10%(v/v) | MCF -7 gem | IC50 = 8.9%(v/v) | Essential oils (variety: TbB) | MTT assay | P815 mastocytoma cell line | IC50 = 8.5%(v/v) | CEM | IC50 = 3.1%(v/v) | K-562 | IC50 = 13.5%(v/v) | MCF -7 | IC50 = 15.4%(v/v) | MCF -7 gem | IC50 = 17.5%(v/v) | Flowers and leaves | Essential oils | MTT assay | P815 mastocytoma cell line | IC50 = 0.016%(v/v) | [21] |
|
|